Page last updated: 2024-10-31

w 12 and Inflammatory Bowel Diseases

w 12 has been researched along with Inflammatory Bowel Diseases in 1 studies

W 12: calmodulin antagonist; W13 analog with Cl deleted from benzene ring

Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.

Research Excerpts

ExcerptRelevanceReference
" Model-informed precision dosing [MIPD; i."1.91A Model-Based Tool for Guiding Infliximab Induction Dosing to Maximize Long-term Deep Remission in Children with Inflammatory Bowel Diseases. ( Dreesen, E; Ferrante, M; Hoffman, I; Kantasiripitak, W; Thomas, D; van Hoeve, K; Vermeire, S; Wicha, SG, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kantasiripitak, W1
Wicha, SG1
Thomas, D1
Hoffman, I1
Ferrante, M1
Vermeire, S1
van Hoeve, K1
Dreesen, E1

Other Studies

1 other study available for w 12 and Inflammatory Bowel Diseases

ArticleYear
A Model-Based Tool for Guiding Infliximab Induction Dosing to Maximize Long-term Deep Remission in Children with Inflammatory Bowel Diseases.
    Journal of Crohn's & colitis, 2023, Jun-16, Volume: 17, Issue:6

    Topics: Child; Drug Monitoring; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Infliximab; Re

2023